Jubbonti | Warnings | MIMS Thailand

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Warnings

Notice: The Sandoz Core Data Sheet (CDS) displays the company's current position on important characteristics of the product, including the Core Safety Information (CSI) according to ICH E2C. The Core Safety Information (Contraindications, Precautions, Interactions, Use in Pregnancy & Lactation, Adverse Reactions and Overdosage required to be listed for the product in all countries, where the product is registered) for all Denosumab containing medicinal products for parenteral (osteoporosis) use is included in this Global Core Data Sheet. However, special information given in Description, Indications/Uses and Dosage & Administration, and Actions and Cautions for Usage may not entirely represent all Denosumab containing medicinal products for parenteral (osteoporosis) use presently on the market.

Jubbonti Warnings

denosumab

Manufacturer:

Novartis Pharmaceutical Manufacturing GmbH

Distributor:

Zuellig Pharma

Marketer:

Sandoz